Related Experiment Video
Updated: Sep 20, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Clinicopathological Patterns and Outcomes in Patients with Lupus Nephritis and Hyperuricemia
Qiong Wen1,2,3, Xueqing Tang1,2,3,4, Qian Zhou5
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
Insights
Hyperuricemia (HUA) in lupus nephritis (LN) patients is common and associated with worse clinicopathological features. However, HUA did not independently predict poor renal outcomes or mortality in this large cohort study.
Area of Science:
- Nephrology
- Rheumatology
- Internal Medicine
Background:
- Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus.
- Hyperuricemia (HUA) is frequently observed in LN patients, but its impact on prognosis is debated.
- Limited large cohort data exist on clinicopathological characteristics and outcomes of LN with HUA.
Purpose of the Study:
- To investigate the clinicopathological features and prognosis of lupus nephritis patients with hyperuricemia.
- To determine if hyperuricemia is an independent risk factor for adverse renal outcomes and mortality in LN.
Main Methods:
- Retrospective cohort study of 1297 LN patients from January 1996 to December 2011.
- Analysis of clinical, laboratory, pathological data, and long-term renal endpoint events and mortality.
- Comparison between patients with and without hyperuricemia.
Main Results:
- Hyperuricemia (HUA) was present in 50.04% of LN patients.
- HUA patients exhibited higher blood pressure, triglycerides, lupus activity, and more severe renal pathology (crescents, inflammation).
- No significant difference in 5- and 10-year renal endpoint event rates or mortality between HUA and non-HUA groups.
Conclusions:
- Hyperuricemia in lupus nephritis patients is associated with more severe disease manifestations and pathological findings.
- Hyperuricemia is not an independent risk factor for poor clinical outcomes or mortality in LN patients.
- Steroid treatment did not influence survival despite delaying renal function deterioration.
Abstract:
A limited number of large cohort studies have reported the clinicopathological characteristics and prognosis of patients with lupus nephritis (LN) and hyperuricemia (HUA). In this retrospective cohort study, 1297 LN patients were enrolled from January 1996 to December 2011 in the First Affiliated Hospital of Sun Yat-Sen University, and HUA occurred in 649 (50.04%) of these 1297 LN patients. Compared to patients without HUA, those with HUA presented with higher blood pressure and triglyceride levels, lower hemoglobin and serum albumin levels, worse renal function, more severe hematuria and proteinuria, higher lupus activity, and more positive antiphospholipid antibody. Pathologically, HUA cases presented more crescents, a higher degree of mesangial matrix, endothelial cell proliferation, and inflammatory cell infiltration. During the 52-month follow-up, the 5-year and 10-year incidence rates of renal endpoint events were 11.1% and 19.5% in the HUA group, and 8.3% and 13.8% in the non-HUA group, respectively (p = 0.073). In addition, the 5-year and 10-year mortality rates did not differ significantly between the HUA (12.0% and 18.2%) and non-HUA (12.2% and 17.5%) groups, respectively. This study verified that HUA was not an independent risk for poor clinical outcomes, and steroids that delay the deterioration of renal function did not affect the survival of these patients.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome III : Nursing Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

